ADLYXIN (Sanofi-Aventis U.S. LLC)
Welcome to the PulseAid listing for the ADLYXIN drug offered from Sanofi-Aventis U.S. LLC. This GLP-1 Receptor Agonist [EPC],Glucagon-Like Peptide 1 [Chemical/Ingredient],Glucagon-like Peptide-1 (GLP-1) Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Sanofi-Aventis U.S. LLC |
| NON-PROPRIETARY NAME: | Lixisenatide |
| SUBSTANCE NAME: | LIXISENATIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | GLP-1 Receptor Agonist [EPC],Glucagon-Like Peptide 1 [Chemical/Ingredient],Glucagon-like Peptide-1 (GLP-1) Agonists [MoA] |
| ROUTE: | SUBCUTANEOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2016-07-27 |
| END MARKETING DATE: | 0000-00-00 |
ADLYXIN HUMAN PRESCRIPTION DRUG Details:
| Item Description | ADLYXIN from Sanofi-Aventis U.S. LLC |
| LABELER NAME: | Sanofi-Aventis U.S. LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 100(ug/mL) |
| START MARKETING DATE: | 2016-07-27 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0024-5747_8c1a83cb-bcbb-40a1-ab02-7d6917f76dd8 |
| PRODUCT NDC: | 0024-5747 |
| APPLICATION NUMBER: | NDA208471 |
Other LIXISENATIDE Pharmaceutical Manufacturers / Labelers:
